Introduction
============

Insight into echocardiographic parameters in the general population may facilitate early recognition of ventricular dysfunction, and reducing the population's morbidity and mortality due to heart failure.[@b1-ARYA-15-009] Echocardiographic parameters can predict cardiovascular events in several clinical settings.[@b2-ARYA-15-009] For decades, metabolic syndrome including obesity has been a major risk factor for cardiovascular diseases (CVDs).[@b3-ARYA-15-009] Recently, the results of observational studies have stated that upper body obesity has a significant association with CVD, hyperinsulinemia, diabetes mellitus (DM), and hypertriglyceridemia independently.[@b4-ARYA-15-009]-[@b7-ARYA-15-009] It has been shown that upper body obesity is correlated with CVDs and metabolic syndrome more than general obesity and body mass index (BMI).[@b8-ARYA-15-009]

There are many different ways to assess upper body obesity. Although imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT), and double X-ray are known as the best methods for estimation of upper body obesity, the excessive costs and adverse effects of radiation has disabled using them as appropriate screening methods. Thus, anthropometric measurements, such as measuring waist circumference (WC), waist to hip ratio, waist to height ratio, and neck circumference (NC), have been suggested as commonly-used simple and non-invasive methods for estimation of upper body obesity.[@b9-ARYA-15-009]-[@b13-ARYA-15-009] Evidence suggests NC as an independent indicator of upper body obesity, associated with metabolic syndrome factors and CVDs.[@b14-ARYA-15-009] As some studies have shown the variation of upper body obesity based on the population's ethnicity and race for predicting DM and CVD,[@b4-ARYA-15-009] and this association has not been studied in Iranian population, in this study, we aimed to determine the association between upper body anthropometric measurements and cardiac diastolic dysfunction in people with normal ejection fraction (EF).

Materials and Methods
=====================

This cross-sectional study was performed in Hajar Hospital, Shahrekord, Iran, from March to August 2014. Eighty participants were selected from those who referred to the cardiovascular clinics, only to accompany a patient. The participants' age ranged from 35 to 50 years, and all were invited to the study after reading and signing the written informed consent form. Any patient with any of the following criteria was excluded from the study: sleep apnea, DM, neck deformity, lymphadenopathy, thyroiditis, thyromegaly, hypertension, left ventricular hypertrophy, EF \< 50%, and valvular heart diseases.

The participants' demographic characteristics were recorded on the study checklist, including positive family history of cardiac disorders and risk factors (like DM, smoking, and hypertension). Participants' height and weight were measured by the researcher with precision of 1 mm and 100 grams, respectively, while the person was wearing light clothing and no shoes; BMI was calculated by dividing weight (in kilograms) by squared height (in meters). The participants were asked to stand straight with their head positioning in Frankfort horizontal level, and a tape measure was placed right under laryngeal prominence around the neck in order to measure the NC. WC was measured while the participants stood up with no clothes, and a tape measure was placed between the last rib and the iliac crest. Systolic (SBP) and diastolic (DBP) blood pressures were measured using an oscillometric approach, and an appropriate cuff was used based on the participants' right arm circumflex. Before measuring BP, all participants relaxed for at least 10 minutes, and BP was measured only once.

Echocardiography was performed using a Vivid 3 Ultrasound Machine (cardiac ultrasound images). Cardiac function parameters such as EF, early diastolic mitral annular (E\'), and late diastolic (A\') velocities were measured by Doppler Tissue Imaging (DTI), and the E/E\' ratio was computed. Recorded mitral inflow measurements included early mitral filling (E) and late (A) velocities, E/A ratio, deceleration time of E velocity, and duration of A.[@b15-ARYA-15-009] Left atrial volume (LAV) was also measured using prolate ellipse method (D1 × D2 × D3 × 0.523).[@b16-ARYA-15-009] Systolic pulmonary artery pressure (SPAP) was measured using tricuspid regurgitation and Bernoulli formula.[@b16-ARYA-15-009] All the measurements were performed by a single investigator and echocardiography assessments were carried out by a fixed individual cardiologist.

All data were analyzed using SPSS software (version 20.0, IBM Corporation, Armonk, NY, USA). Numerical measurements were normally distributed and reported as mean ± standard deviation (SD). Two samples t test was used to compare mean differences of cardiac function parameters between men and women participants. Pearson correlation coefficient was calculated to evaluate association between anthropometric measures (NC and WC) and cardiac function parameters. To avoid multiplicity problem, Bonferroni correction was applied. P-values of less than 0.050 were considered statistically significant.

Results
=======

Eighty subjects (54 women and 26 men) with mean (± SD) age of 40.0 (± 8.1) years participated in this study. None of the participants were a known case of CVDs or DM. The mean values of BMI, NC, WC, and BP are presented in [table 1](#t1-ARYA-15-009){ref-type="table"}. Independent t test showed that the difference between the mean age and BMI of the women and men were not statistically significant (P \> 0.050). But, there were significant differences between men and women in terms of other variables such as height and weight, NC, and WC (P \< 0.050 for all).

The correlation of NC, WC, and BMI with echocardiographic variables and BP was tested for men and women, and the results of which are shown in [tables 2](#t2-ARYA-15-009){ref-type="table"} and [3](#t3-ARYA-15-009){ref-type="table"}, respectively.

According to [table 2](#t2-ARYA-15-009){ref-type="table"}, for men, NC had a positive correlation with LAV, SBP, pulmonary arterial pressure (PAP), A\', and DBP, and a negative correlation with E′. WC had a significantly positive correlation with LAV, SBP, and PAP, but a negative correlation with E′. BMI had a significantly positive correlation with LAV, PAP, SBP, A, and A'.

According to [table 3](#t3-ARYA-15-009){ref-type="table"}, for women, NC had a positive correlation with LAV, A, EF, SBP, PAP and A' and a negative correlation with E′ and E/E′. WC had a significant correlation with LAV, DBP, PAP, A, and A' and a negative correlation with E′. BMI had a significant positive correlation with PAP, E', LAV, EF, SBP, A, and A'.

Discussion
==========

The results of this study indicated that NC was significantly correlated with LAV, SBP, DBP, and PAP, which shows that all of them can be used as predictors of probable myocardial diastolic dysfunction. WC and BMI were also correlated with parameters, predicting the probability of myocardial dysfunction, but they both had a rather weaker correlation, compared to NC. Preis et al. showed that NC could be a marker of fat deposit, associated with great potential risk of CVDs.[@b8-ARYA-15-009] Ben-Noun and Laor also recognized the positive association between NC and some features of metabolic syndrome, predicting the risk of CVDs.[@b14-ARYA-15-009] The results of both studies are in line with that of ours.

In our study, NC was associated with SBP and DBP. In previous studies, the relationship between NC and BMI or WC has been addressed in order to show the relation between NC and metabolic syndrome.[@b4-ARYA-15-009]-[@b8-ARYA-15-009] Our study is in line with these statements, but adds the correlation of NC, another item of the metabolic syndrome, with SBP and DBP. This indicates that NC can be a potent criterion in metabolic syndrome and probable CVDs, which could be associated with the aforementioned matters. In our study, there was a strong negative correlation between NC and E\', and a weak negative correlation between E\' with WC and BMI, which shows that E\' can be a better predictor for cardiac diastolic dysfunction than BMI and WC.

For many years, BMI has been used to evaluate obesity, as a risk factor of CVDs. Also many studies have considered central obesity and WC as important markers for predicting CVDs.[@b17-ARYA-15-009]-[@b20-ARYA-15-009] Similarly, the results of our study confirmed the association between WC with different echocardiographic parameters and SBP.

Looking to the whole picture reveals a stronger association between NC and echocardiographic parameters, compared to general obesity and WC. This is in line with studies that present upper body fat deposit as a better predictor of CVDs.[@b6-ARYA-15-009]-[@b22-ARYA-15-009]

In our study, there was no significant correlation between NC and EF in neither sexes. This finding may be due to including only participants with EF of more than 50%. Thus, further studies are needed to evaluate the relation between NC and EF in participants with a wide range of EFs. Similarly, there was no significant correlation between NC and E/E\' in men. The inclusion of participants with EF of more than 50% could be the reason for this finding; as E/E\' is mainly impaired in advanced diastolic dysfunction, whereas in this study all cases were healthy, and no abnormality in E/E\' ratio was expected.

The cross-sectional study design is main drawback of our findings, as it is not possible to discuss the causal relationship between anthropometric indices and cardiac function. Furthermore, the fact that the studied participants came from a healthy population, could be either considered as a positive point or a limitation. Many patients with CVDs suffer from obesity and metabolic syndrome concurrently, and we excluded patients with CVD or DM to decrease the risk of bias in our study. On the other hand, such an inclusion criteria could be a limitation for studying the association between NC and some pathological features such as EF and E/E\'.

Conclusion
==========

In this study, it was observed that NC, WC, and BMI had a significant correlation with LAV and PAP, both in men and women. NC had a significant correlation with SBP in men and women, and also BMI had significant correlation with A in both sexes. These findings imply that these measures may help refine evaluations of metabolic and cardiovascular risk factors. Accordingly, regular NC, WC, and BMI screening is recommended as an easy and effective way of assessing body weight for prevention of weight-related diseases in men and women.
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###### 

The demographic characteristics of participants

  Variable        Men (n = 26)   Women (n = 54)   Total (n = 80)   P
  --------------- -------------- ---------------- ---------------- -------
  Age (year)      41.5 ± 7.3     39.2 ± 8.3       40.0 ± 8.1       0.227
  Height (cm)     171.8 ± 9.7    160.3 ± 6.1      40.0 ± 8.1       0.003
  Weight (kg)     82.3 ± 15.1    71.2 ± 12.7      40.0 ± 8.1       0.001
  NC (cm)         40.1 ± 3.4     35.6 ± 3.1       37.1 ± 3.8       0.023
  WC (cm)         94.9 ± 12.5    83.5 ± 11.5      87.2 ± 12.9      0.008
  SBP (mmHg)      120.9 ± 6.6    114.3 ± 7.5      116.5 ± 7.8      0.040
  DBP (mmHg)      80.7 ± 5.9     76.2 ± 5.5       77.7 ± 6.0       0.001
  BMI (kg/m^2^)   27.8 ± 4.4     27.7 ± 4.8       27.7 ± 4.6       0.879

Data are reported as mean ± standard deviation (SD).

NC: Neck circumference; WC: Waist circumference; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; BMI: Body mass index

###### 

The correlation of neck circumference (NC), waist circumference (WC), and body mass index (BMI) with echocardiographic parameters in men

  Variable     NC (cm)   WC (cm)    BMI (kg/m^2^)                       
  ------------ --------- ---------- --------------- ---------- -------- ----------
  LAV (ml)     0.968     \< 0.001   0.668           \< 0.001   0.641    \< 0.001
  EF (%)       0.060     0.298      -0.124          0.137      0.103    0.365
  SBP (mmHg)   0.442     \< 0.001   0.387           \< 0.001   0.291    0.009
  DBP (mmHg)   0.239     0.030      0.143           0.200      0.133    0.239
  PAP (mmHg)   0.777     \< 0.001   0.679           \< 0.001   0.500    \< 0.001
  A (cm/s)     0.469     0.008      0.084           0.342      0.337    0.046
  A\' (cm/s)   0.612     \< 0.001   0.185           0.182      0.379    0.029
  E\' (cm/s)   -0.410    \< 0.001   -0.383          \< 0.001   -0.269   0.008
  E/E\'        -0.015    0.447      -0.024          0.416      0.088    0.437

P-values of less than 0.050 were considered as statistically significant.

NC: Neck circumference; WC: Waist circumference; BMI: Body mass index; LAV: Left atrial volume; EF: Ejection fraction; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; PAP: Pulmonary arterial pressure; A: Peak velocity of mitral inflow during atrial contraction, A′: Late diastolic mitral annular velocity, E: Peak velocity of mitral inflow during early filling phase; E′: Early diastolic mitral annular velocity

###### 

The correlation of neck circumference (NC), waist circumference (WC), and body mass index (BMI) with echocardiographic parameters in women

  Variable     NC (cm)   WC (cm)    BMI (kg/m^2^)                   
  ------------ --------- ---------- --------------- ------- ------- ----------
  LAV (ml)     0.935     \< 0.001   0.541           0.008   0.722   0.030
  EF (%)       0.270     0.024      -0.120          0.465   0.277   0.021
  SBP (mmHg)   0.290     0.017      0.182           0.094   0.354   0.004
  DBP (mmHg)   0.134     0.167      0.143           0.024   0.136   0.164
  PAP (mmHg)   0.289     0.017      0.693           0.003   0.596   \< 0.001
  A (cm/s)     0.555     \< 0.001   0.446           0.002   0.472   0.002
  A\' (cm/s)   0.589     0.030      0.489           0.003   0.372   0.003
  E\' (cm/s)   -0.382    \< 0.001   -0.234          0.038   0.399   \< 0.001
  E/E\'        -0.123    0.002      -0.075          0.294   0.207   0.067

P-values of less than 0.050 were considered as statistically significant.

NC: Neck circumference; WC: Waist circumference; BMI: Body mass index; LAV: Left atrial volume; EF: Ejection fraction; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; PAP: Pulmonary arterial pressure; A: Peak velocity of mitral inflow during atrial contraction, A′: Late diastolic mitral annular velocity, E: Peak velocity of mitral inflow during early filling phase; E′: Early diastolic mitral annular velocity
